Your browser doesn't support javascript.
loading
[Applicability of a natural swelling matrix as the propellant of osmotic pump tablets].
Wu, Li; Li, Hai-Yan; Yin, Xian-Zhen; Li, Ying; Chen, Jian-Xiu; Hu, Rong-feng; Zhang, Ji-Wen.
Afiliación
  • Wu L; Anhui University of Traditional Chinese Medicine, Hefei 230038, China.
Yao Xue Xue Bao ; 48(8): 1319-24, 2013 Aug.
Article en Zh | MEDLINE | ID: mdl-24187843
The purpose of this study is to investigate the applicability of a natural swelling matrix derived from boat-fruited sterculia seed (SMS) as the propellant of osmotic pump tablets. The sugar components, static swelling, water uptake and viscosity of SMS were determined and compared with that of polythylene oxide (WSR-N10 and WSR-303). Both ribavirin and glipizide were used as water-soluble and water-insoluble model drugs. Then, the monolayer osmotic pump tablets of ribavirin and the bilayer osmotic pump tablets of glipizide were prepared using SMS as the osmotically active substance and propellant. SMS was mainly composed of rhamnose, arabinose, xylose and galactose and exhibited relatively high swelling ability. The area of the disintegrated matrix tablet was 20.1 times as that at initial after swelling for 600 s. SMS swelled rapidly and was fully swelled (0.5%) in aqueous solution with relative low viscosity (3.66 +/- 0.03) mPa x s at 25 degrees C. The monolayer osmotic pump tablets of ribavirin and the bilayer osmotic pump tablets of glipizide using SMS as propellant exhibited typical drug release features of osmotic pumps. In conclusion, the swelling matrix derived from boat-fruited sterculia seed, with low viscosity and high swelling, is a potential propellant in the application of osmotic pump tablets.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Ribavirina / Tecnología Farmacéutica / Malvaceae / Glipizida Idioma: Zh Revista: Yao Xue Xue Bao Año: 2013 Tipo del documento: Article País de afiliación: China
Buscar en Google
Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Ribavirina / Tecnología Farmacéutica / Malvaceae / Glipizida Idioma: Zh Revista: Yao Xue Xue Bao Año: 2013 Tipo del documento: Article País de afiliación: China